Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance

S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - mdpi.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …

Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a …

S Karakonstantis, M Rousaki, L Vassilopoulou… - Clinical Microbiology …, 2023 - Elsevier
Background Cefiderocol is a last resort option for carbapenem-resistant (CR) Gram-negative
bacteria, especially metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and …

Current and potential therapeutic options for infections caused by difficult-to-treat and pandrug resistant gram-negative bacteria in critically ill patients

H Giamarellou, I Karaiskos - Antibiotics, 2022 - mdpi.com
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …

Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on …

R Dehbanipour, Z Ghalavand - Journal of Clinical Pharmacy …, 2022 - Wiley Online Library
What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Bacteriophages in infectious diseases and beyond—A narrative review

P Ioannou, S Baliou, G Samonis - Antibiotics, 2023 - mdpi.com
The discovery of antibiotics has revolutionized medicine and has changed medical practice,
enabling successful fighting of infection. However, quickly after the start of the antibiotic era …

Multidrug-Resistant Acinetobacter baumannii in Jordan

M Al-Tamimi, H Albalawi, M Alkhawaldeh, A Alazzam… - Microorganisms, 2022 - mdpi.com
Background: Acinetobacter baumannii is a common cause of multi-drug (MDR)-resistant
infections worldwide. The epidemiological and molecular characteristics of MDR-A …

Effectiveness and nephrotoxicity of loading dose colistin–meropenem versus loading dose colistin–imipenem in the treatment of carbapenem-resistant Acinetobacter …

W Katip, P Oberdorfer, N Kasatpibal - Pharmaceutics, 2022 - mdpi.com
Carbapenem-resistant Acinetobacter baumannii (CRAB) is becoming more widely
recognized as a serious cause of nosocomial infections, and colistin has been reintroduced …

Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case Series …

SF Assimakopoulos, V Karamouzos, G Eleftheriotis… - Pathogens, 2023 - mdpi.com
Acinetobacter baumannii (AB) has evolved over the last decades as a major problem in
carbapenem-resistant gram-negative nosocomial infections, associated with high mortality …

[HTML][HTML] Antibiotic therapy for pan-drug-resistant infections

MA Ozma, A Abbasi, M Asgharzadeh… - Le infezioni in …, 2022 - ncbi.nlm.nih.gov
Antibiotic resistance occurs when microorganisms resist the drugs used against the infection
caused by them and neutralize their effects over time using various mechanisms. These …

Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates

MM Almutairi - PLoS One, 2022 - journals.plos.org
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning
because of the limited therapeutic choices for these important clinical pathogens. We …